Mr. Seamus McCarthy:

The remit of the commercialisation committee was to review all agreements and assignments of interest in IP. That was set out in the policy in February 2010. I was drawing attention to the fact that the committee had its first meeting prior to the transfer of the IP but it did not consider the transfer at all. It is anomalous.